3-hydroxy-3-methylglutaryl-coenzyme a has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, H; Guo, D; Jia, Y; Liu, F; Shi, M; Sun, L; Wang, Y; Yang, P; Zhang, Y; Zhu, Z | 1 |
| Freeman, MR; Solomon, KR | 1 |
2 review(s) available for 3-hydroxy-3-methylglutaryl-coenzyme a and Cancer of Prostate
| Article | Year |
|---|---|
Associations of genetically proxied inhibition of HMG-CoA reductase, NPC1L1, and PCSK9 with breast cancer and prostate cancer.
Topics: Acyl Coenzyme A; Breast Neoplasms; Cholesterol, LDL; Coenzyme A; Genome-Wide Association Study; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Membrane Transport Proteins; Mendelian Randomization Analysis; Oxidoreductases; Proprotein Convertase 9; Prostatic Neoplasms; Receptors, Estrogen | 2022 |
Cholesterol and prostate cancer.
Topics: Acyl Coenzyme A; Cholesterol; Humans; Male; Membrane Microdomains; Prostatic Neoplasms; Signal Transduction | 2004 |